« Six degrees of pharmacology | Main | The biggest bang of them all »

GM patent rejected after 13 years

Patent for technology to fire genes into soy seeds thrown out.

The European Patent Office (EPO) has revoked a patent owned by global agricultural giant Monsanto for the genetic modification (GM) of soybeans, saying the technique it approved 13 years ago lacked "novelty".

Read the story here.

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/2478

Comments

Thanks for your article on European Patent Office's decision to revoke Monsanto's species-wide patent on all genetically modified soybeans. I represented ETC Group at the appeal board hearing, and I can tell you that Monsanto cares deeply about its patent -- and is not happy about the outcome -- despite the fact that the patent expires in a matter of months. ETC Group, a civil society organization based in Canada, maintained its 13-year legal battle against Monsanto, not merely as a position against GM crops as you suggest, but because of Monsanto's far-reaching, exclusive monopoly on one of the world's most important food crops. It was shameful that EPO took nine years to schedule the first opposition hearing, and 4 more years to schedule an appeal tribunal. We won on technical grounds -- but the real issue is control and ownership of the world's food supply, and the rights of farming communities. The bigger message here is that the patent system is broken and hopelessly incompetent.
For more on ETC Group's position, and background on the patent, please see: http://www.etcgroup.org/en/

It is strange that a patent is revoked after 13 years.Recently a broad patent on stem cells was
held invalid. If patents are revoked or held invalid
after years on one ground
or another, it raises
questions about their grant
in the first place.

Thanks for the news and agree with you...

Your report is very slightly inaccurate. It was not 'the technique' of transforming soya using a particle gun that the EPO Appeal Board found not novel, but the product claims: to (all) soya containing an expressed 'foreign gene'. We await the full written decision, but the Board seems to have considered that these claims would cover known 'wide crosses' eg between Soya glycine and Soya max.

The 'technique' claims were also found invalid, for a different reason - namely that the technique was not described in a way that enabled the skilled person to repeat it. Normally the EPO is reluctant to find patents invalid on this ground, at least where there is a detailed description (as there was here) but unusually Monsanto were unable convincingly to challenge the evidence about this, because they filed it themselves (when they opposed the patent originally).

The claims were also challenged as obvious, in view of the Klein disclosure in 'Nature' which you cite, and on other grounds (too broad, immoral, etc) but the Board, having found the claims invalid on other grounds, made no decison on these points.

Dear Sir, the link to the news item is broken. Could you fix it? Thank you...

[Editor's note. Apologies. Due to the recent site redesign, these links are temporarily not working. In the meantime, you can find them by inserting the word 'news' into the URL like this:
http://www.nature.com/news/2007/070430/full/news070430-14.html ]

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.